$36.43
0.010.03%
Last update: Nov 9, 7:13 AM
Pacira BioSciences Inc
PCRXNASDAQ
The average analyst price target for Pacira BioSciences is $36.07, 1.1% below the current price. Of 11 analysts, 4 rate it Buy and 7 Hold. Targets range from $18 to $65. The latest change came on Oct 9, 2026, when Truist Securities downgraded Pacira BioSciences from Buy to Hold and moved its price target from $31 to $36.50.
Price Target Range — 12 Quarters
Analyst Consensus — 11 Analysts
Rating Trend — Last 9 Months
